We are excited to introduce AURA: The world’s first end-to-end automation of the IVF lab. This is not theoretical. We are already achieving pregnancies. AURA performs the more than 200 steps necessary to combine sperm and eggs to create viable embryos. Conceivable’s AURA workcell will be operational in early 2025 and we can’t wait to work with clinicians everywhere to improve IVF outcomes, increase scale, and lower costs. Alan Murray, Joshua Abram, Alejandro Chavez-Badiola, MD, PhD, Jacques Cohen, Mina Alikani, Brian A. Levine, MD, MS, FACOG, Brian Bixon, David Sable, Aike Ho, Dr Stephanie Kuku, MD #IVFAutomation #IVF Watch the film and see the future now:
Conceivable Life Sciences
生物技术研究
New York，New York 4,098 位关注者
Pioneering the world's first end-to-end automated IVF lab.
关于我们
Conceivable has developed the world’s first fully automated IVF lab. Our end-to-end reinvention of today’s largely manual, artisanal labs delivers new levels of precision, quality, and scalability. Simultaneously, Conceivable brings the innovation of modern cell therapies to IVF. We are already exceeding the clinical benchmarks of today’s best IVF labs. Worldwide 95% of the infertile population–and 80% in the United States–don’t have access to IVF. Conceivable exists to change this. By automating the IVF lab we will vastly broaden the availability to this Nobel Prize winning therapy, improve results, and meet the demands of millions of infertile people wishing to achieve the dream of becoming parents.
- 网站
-
https://www.conceivable.life
Conceivable Life Sciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- New York，New York
- 类型
- 私人持股
- 创立
- 2022
地点
-
主要
获取路线
160 Mercer Street
US，New York，New York，10012
Conceivable Life Sciences员工
动态
-
Conceivable Life Sciences is the ultimate family business. That’s not a slogan so much as it’s a commitment to a mission focused on helping millions of people achieve the dream of becoming parents. In that spirit we support the United Nations and UNICEF in its celebration of World Children's Day and the goal "to promote international togetherness, awareness among children worldwide, and improving children's welfare." #WorldChildrensDay
Today is a day of action for children, by children! Today is #WorldChildrensDay.
-
Our CEO Alan Murray does a little math around the shortage of IVF doctors, embryologists, and how our AURA lab can help address these issues. #IVF #IVFautomation #automation #biotechnology #biotechadvancement #healthcaretechnology #fertility
????,??????,?????? ???????????? ???????? ???????????? ???????????????????? ?????? ????????: Last year Dr. Eduardo Hariton led a team of REIs and clinicians to produce a paper (link in comments) on the looming shortage of IVF doctors required to meet patient demand. Since that time California has mandated access to IVF and our future president has proposed a national mandate. All data point to a 5x increase in IVF cases or 2 million per year in the U.S.. In the paper, Hariton proposes ways to accelerate training and recommends cross-training other doctors to pick up the workload. Left unsaid is the other (perhaps larger) bottleneck in care delivery: the embryologists. To put the demands on embryologists in perspective, just look at the numbers as they relate to the volume of single cell manual procedures required each year to service 2 million IVF cycles. Annual IVF Cycles in the US:?2,000,000 Eggs Isolated and Denuded:? 24,000,000 Sperm Selected:? 24,000,000 ICSI:? 24,000,000 Embryos vitrified: 10,000,000 ?????????????????????????? ????,??????,?????? ???????????? ???????????????????? ? Attempts to address the embryologist staffing crisis—highlighted by an estimated 400 unfilled positions in the U.S.—are akin to a whisper in a hurricane. This shortage can be directly tied to the stress and burnout that is the result of the demanding nature of embryology and its long hours and immense responsibility in high-stakes environments. At Conceivable Life Sciences, we offer a transformative solution: our AURA end-to-end automated IVF lab. Capable of performing 2,000 IVF cycles annually, it requires only 400 square feet of space. By integrating automation, we reduce the demand of manual processes, offering a scalable and sustainable path to meet rising demand while maintaining precision and consistency in care. #IVF #IVFautomation?#automation #biotechnology #biotechadvancement #healthcaretechnology #fertility Ruben Alvero COL Micah Hill Rachel Weinerman Steven Young Shady Grove Fertility David Sable Jennifer Mersereau Shana Perman, PA-C Fiona W. Pardis Hosseinzadeh Anthony Imudia Erica Johnstone Ruth Lathi Paul Lin Erica M. Michele Munch Gloria Ríchard-Davis, MD, MBA, FACOG, MSCP FACOG Steven Young
-
Here's our Chief Scientific Officer Jacques Cohen talking about the importance of egg discovery and preparation. Stick around for the second piece of the video to catch a glimpse of the latest version of our end-to-end automated AURA IVF lab. #IVF #IVFautomation? #automation #biotechnology #biotechadvancement #healthcaretechnology #fertility
In a video made 12 months ago, our Chief Scientific Officer Jacques Cohen talked about the challenges of the present system of manual egg discovery and denudation. Watching it again got me thinking about how far Conceivable Life Sciences has come in the last year. We have not only completed our Egg discovery workstation, but are launching our fully automated AURA IVF lab in January of 2025, of which fully automated egg discovery and prep are a part. #IVF #IVFautomation? #automation #biotechnology #biotechadvancement #healthcaretechnology #fertility
-
Our Chairman Joshua Abram spoke with our Muse Capital investors Assia Grazioli-Venier and Rachel Springate for their podcast. Here he discusses how our automated AURA lab will address critical issues like cost and accessibility.
Recently I joined Assia Grazioli-Venier and Rachel Springate, founders at Muse Capital—and Conceivable Life Sciences investors—for their podcast . We had an energizing conversation about all things IVF, including cost and accessibility. In this segment, we dive into how Conceivable’s end-to-end automation of the IVF lab (AURA) is set to address these critical issues, bringing this Nobel prize winning therapy to millions of people. #IVF #IVFautomation #automation #biotechnology #venturecapital
-
We admire our investors and their thinking. In a recent conversation with?Aike Ho of?ACME Group she told us the?following: "A quality I look for in a partner, a friend, a founder is velocity of growth. If you're still the same person a year ago from where you are?today, that's pretty boring. So much of living is growing." At Conceivable, we embody this philosophy. As we approach our clinical launch in January, we are proud of our team's "velocity of growth" and our commitment to continuous innovation and improvement. It drives us to?constantly?evolve our technology, our processes, and our mission to help millions of?people achieve the?dream of?becoming parents. #IVF #IVFAutomated #FertilityCare #IVF #HealthcareInnovation #AccessibleHealthcare
-
-
It’s always amazing to have our Chief Knowledge Officer in NYC. We miss you already Dr Stephanie Kuku, MD !
It was a pleasure to be in NYC for The Galien Foundation USA Forum at Alexandria Center for Life Science and awards at the American Museum of Natural History as a guest of the formidable Bruno Cohen. As a member of the Galien UK Judging committee it was particularly wonderful to see Dr Chris Mansi of Viz.ai on stage with the one and only Isaac Kohane moderating the fantastic closing panel on Artifical Intelligence in Health with Michelle Longmire, Erika Stanzl , Ajay Gannerkote and John Halamka, M.D., M.S. . The President’s dinner pre-forum at the United Nations hosted by committee chairs Kenneth C. Frazier and Michael Rosenblatt was special and I was delighted to attend with my colleague Shivani Nookala of Conceivable Life Sciences. #prixgalien #biotech #biopharma #medicaltechnology #startups #artificialintelligence #lifesciences #healthcare
-
-
Are you interested in AI and it's place in the ART laboratory? Our co-founder Alejandro Chavez-Badiola, MD, PhD and our Chief Scientific Officer Jacques Cohen published an insightful paper in Reproductive BioMedicine Online (with Giles Palmer, Omar Paredes, Andrew Drakeley, Thomas Woolley, Katerina Kaouri). Click the link in the comments. #AI #IVFautomation #IVF #ART #automation #biotechnology IVF20.ai
-
We are excited to introduce AURA: The world’s first end-to-end automation of the IVF lab. This is not theoretical. We are already achieving pregnancies. AURA performs the more than 200 steps necessary to combine sperm and eggs to create viable embryos. Conceivable’s AURA workcell will be operational in early 2025 and we can’t wait to work with clinicians everywhere to improve IVF outcomes, increase scale, and lower costs. Alan Murray, Joshua Abram, Alejandro Chavez-Badiola, MD, PhD, Jacques Cohen, Mina Alikani, Brian A. Levine, MD, MS, FACOG, Brian Bixon, David Sable, Aike Ho, Dr Stephanie Kuku, MD #IVFAutomation #IVF Watch the film and see the future now:
-
Milestone Achieved! ?? Today marks a significant milestone at Conceivable Life Sciences as we successfully completed the environmental, perormance and preclinical validation phase of C:DISH, our innovative robotic solution designed to prepare dishes for AURA, the end to end automation solution for the IVF lab. Hundreds of dishes have been meticulously prepared under strict quality control protocols, including rigorous toxicity tests (MEA), air quality assessments, pH measurements, osmolality checks, and many more. We're thrilled to announce that C:DISH is now ready to be tested in a real-world setting. This is a major step forward in our mission to standardize the IVF process, enhancing efficiency, accuracy, and patient outcomes. AURA is real, is here and its beautiful. #robotics #IVF #lifesciences #milestone #validation #CDish #AURA Especially thanks to Jacques Cohen, Mina Alikani Nuno Costa Borges, Carla Patricia Barragán álvarez, Karen Aleriano, Sofia Anahi Real Covarrubias, Regina Curiel
-